Terbutaline Sulfate
TERBUTALINE SULFATE INJECTION, USP
Approved
Approval ID
6a22b62c-4ee1-49df-e053-2a91aa0a3e52
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 23, 2023
Manufacturers
FDA
Medical Purchasing Solutions. LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Terbutaline Sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71872-7080
Application NumberANDA078630
Product Classification
M
Marketing Category
C73584
G
Generic Name
Terbutaline Sulfate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateMay 23, 2023
FDA Product Classification
INGREDIENTS (4)
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
TERBUTALINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: 576PU70Y8E
Classification: ACTIB